These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 17699452

  • 1. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS.
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL.
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G, Chaturvedi N.
    Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR.
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regression of microalbuminuria in type 1 diabetes.
    Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS.
    N Engl J Med; 2003 Jun 05; 348(23):2285-93. PubMed ID: 12788992
    [Abstract] [Full Text] [Related]

  • 14. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar 05; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study.
    Stone ML, Craig ME, Chan AK, Lee JW, Verge CF, Donaghue KC.
    Diabetes Care; 2006 Sep 05; 29(9):2072-7. PubMed ID: 16936155
    [Abstract] [Full Text] [Related]

  • 18. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM, Palmer BF, Ram CV.
    Postgrad Med; 2005 Dec 05; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W, MARPLE Study Group.
    J Hypertens; 2006 Mar 05; 24(3):541-8. PubMed ID: 16467658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.